Career menu

Start
Departments

Employee login Log in

Connect

Departments

Preclinical Research
Technical Operations
Clinical Development
Finance & Administration

About BioInvent

BioInvent develops the next generation of immune-oncology therapies

BioInvent is generating value for shareholders by employing its antibody and cancer biology expertise to identify antibodies with novel mechanisms-of-action and novel oncology targets. The Company employs this approach to generate therapeutic immuno-modulating antibodies that can be developed for a broad range of cancer indications. The Company plans to bring these antibodies to the clinic through its own resources and together with partners.

Career site

Start
Departments

Departments

Preclinical Research
Technical Operations
Clinical Development
Finance & Administration

Users

Candidate login
Employee login
Data & privacy

Career site by Teamtailor